Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Biognosys’ Spectronaut™ Software Now Supports Thermo Scientific™ Proteome Discoverer™ Platform
Monday, October 27, 2014
Proteome Discoverer™ users can generate spectral libraries with Spectronaut™ software.

Tecan’s AC Extraction Plate™ Boosts Productivity for Clozapine Testing
Saturday, October 25, 2014
King’s College Hospital has established a fully automated therapeutic drug monitoring protocol for clozapine.

New Orbitrap-based Mass Spectrometer Launched
Monday, October 20, 2014
New Orbitrap-based mass spectrometer makes high-resolution accurate-mass analysis widely accessible.

New Compact SIMS to Launch at Vacuum Expo 2014
Tuesday, October 14, 2014
Designed for fast and easy characterization of layer structures, surface contamination and impurities of positive ions.

New Compact SIMS - Mass Spectrometry in Solid Material
Saturday, October 04, 2014
Designed for fast and easy characterization of layer structures, surface contamination and impurities.

Protea Biosciences and InSphero Successful in Mass Spectrometry Imaging of 3D Microtissues
Saturday, October 04, 2014
Protea to present data at upcoming InSphero User Group Meetings.

EPIC Research Tool for Ultra-High Vacuum
Thursday, September 25, 2014
New EPIC quadrupole mass spectrometer from Hiden.

New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph from Shimadzu
Wednesday, September 17, 2014
The system empowers laboratories to separate even the most complex mixtures.

Diagnostic Tool for Therapeutic Plasma Medicine
Tuesday, September 09, 2014
HPR-60 mass spectrometer for direct measurement of reactive and gaseous species.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1107
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv